multiparameter optimization algorithm (cns mpo) (Pfizer Inc)
90
Structured Review
Pfizer Inc
multiparameter optimization algorithm (cns mpo)
Multiparameter Optimization Algorithm (Cns Mpo), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/multiparameter+optimization+algorithm/pmc08308832-678-23-17
Average 90 stars, based on 1 article reviews
Multiparameter Optimization Algorithm (Cns Mpo), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/multiparameter+optimization+algorithm/pmc08308832-678-23-17
Average 90 stars, based on 1 article reviews
multiparameter optimization algorithm (cns mpo) - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Establishment of a Structure–Activity Relationship of 1H-Imidazo[4,5-c]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness Article Snippet: In evaluating analogue designs, we employed the multiparameter optimization (MPO) algorithm developed by Article Title: Medicinal Chemistry strategies for PET tracer discovery. Article Snippet: The detection of gamma rays, resulting from decay of positron emitting isotopes, allows exquisitely sensitive detection of probes radiolabeled with such isotopes.. These probes can be designed for high affinity binding to specific molecular targets and be used as tools in the early development of drugs, particularly for neuropsychiatric disorders.. Availability of novel tracers requires dedicated resources and selection assays. Article Title: Establishment of a Structure–Activity Relationship of 1 H -Imidazo[4,5- c ]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness Article Snippet: In evaluating analogue designs, we employed the multiparameter optimization (MPO) algorithm developed by Article Title: Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement Article Snippet: These compounds were designed to penetrate the blood–brain barrier by use of the Article Title: Synthesis, structural characterization, computational studies, and antifungal activity of isoniazid derivative Article Snippet: In this work, the isoniazid derivative N’,N’’’-((1E,1′E)-1,4-phenylenebis(methaneylylidene))di(isonicotinohydrazide) (BISHDZHI) was synthesized and characterized by Nuclear Magnetic Resonance (NMR), Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR), Fourier Transform Raman (FT-Raman), and Ultraviolet-Visible (UV–Vis) spectroscopy, and its potential against fungal strains of Candida ssp. was evaluated by in vitro assays.. The NMR spectrum confirmed the molecular structure of BISHDZHI.. Quantum chemistry computational calculations allowed to obtain the potential energy surface, optimized molecular structure, and to identify all the bands of the Raman, infrared and UV spectra. Article Title: Structural modifications that alter the P-glycoprotein efflux properties of compounds. Article Snippet: Retrospective analysis of marketed drugs has revealed that very low prevalence of P-glycoprotein (P-gp) efflux and moderate to high passive permeability are two key properties that distinguish drugs which engage targets in the central nervous system (CNS) from those that act predominantly in the periphery.. Quantification of the efflux properties that differentiate CNS drugs has been determined using in vitro assays for human and rodent P-gp, and revealed in vivo by comparing brain drug exposures in P-gp (mdr1a/b(−/−)) knockout mice against those observed in wild type mice.. Recognition by P-gp not only dramatically affects the distribution properties of compounds into bodily compartments including the CNS, testis, and placenta but also confers resistance to certain cancer chemotherapeutics. Article Title: Strategies for Structural Modification of Small Molecules to Improve Blood-Brain Barrier Penetration: A Recent Perspective. Article Snippet: In the development of central nervous system (CNS) drugs, the blood−brain barrier (BBB) restricts many drugs from entering the brain to exert therapeutic effects.. Although many novel delivery methods of large molecule drugs have been designed to assist transport, small molecule drugs account for the vast majority of the CNS drugs used clinically.. From this perspective, we review studies from the past five years that have sought to modify small molecules to increase brain exposure. Permeability:Article Title: Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma Article Snippet: .. An algorithm including six physicochemical parameters for assessing the BBB permeability of |